Directori de persones
Jose Manuel Valdivielso Revilla

Jose Manuel Valdivielso Revilla

Grau: Doctor

973 702 952
valdivielso(ELIMINAR)@irblleida.cat

ResearcherID: http://www.researcherid.com/rid/B-5673-2009

Publicacions

  • Bermudez-Lopez M; Forne C; Amigo N; Bozic M; Arroyo D; Bretones T; Alonso N; Cambray S; Del Pino MD; Mauricio D; Gorriz JL; Fernandez E; Valdivielso JM

    An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients

    Expert Opinion On Therapeutic Targets 1-12. .

    [doi:10.1080/14728222.2019.1620206]

  • Sanchez, Enric; Betriu, Angels; Yeramian, Andree; Fernandez, Elvira; Purroy, Francesc; Sanchez-de-la-Torre, Manuel; Pamplona, Reinald; Miquel, Eva; Kerkeni, Mohsen; Hernandez, Cristina; Simo, Rafael; Lecube, Albert; Hernandez, Marta; Rius, Ferran; Polanco, Dinora; Barbe, Ferran; Torres, Gerard; Suarez, Guillermo; Portero-Otin, Manuel; Jove, Mariona; Colas-Campas, Laura; Benabdelhak, Ikram; Farras, Cristina; Ortega, Marta; Manuel Valdivielso, Jose; Bermudez-Lopez, Marcelino; Martinez-Alonso, Montse; ILERVAS project; ILERVAS Project:

    Skin Autofluorescence Measurement in Subclinical Atheromatous Disease: Results from the ILERVAS Project.

    Journal of Atherosclerosis and Thrombosis -. .

    [doi:10.5551/jat.47498]

  • Valls J; Cambray S; Pérez-Guallar C; Bozic M; Bermúdez-López M; Fernández E; Betriu À; Rodríguez I; Valdivielso JM

    Association of Candidate Gene Polymorphisms With Chronic Kidney Disease: Results of a Case-Control Analysis in the Nefrona Cohort

    Frontiers in Genetics 10 118-118. .

    [doi:10.3389/fgene.2019.00118]

  • Ferro, Charles J.; Mark, Patrick B.; Kanbay, Mehmet; Sarafidis, Pantelis; Heine, Gunnar H.; Rossignol, Patrick; Massy, Ziad A.; Mallamaci, Francesca; Valdivielso, Jose M.; Malyszko, Jolanta; Verhaar, Marianne C.; Ekart, Robert; Vanholder, Raymond; London, Gerard; Ortiz, Alberto; Zoccali, Carmine

    Lipid management in patients with chronic kidney disease (vol 14, pg 727, 2018)

    NATURE REVIEWS NEPHROLOGY 15 121-121. .

    [doi:10.1038/s41581-018-0099-y]

  • Sarafidis, Pantelis; Ferro, Charles J.; Morales, Enrique; Ortiz, Alberto; Malyszko, Jolanta; Hojs, Radovan; Khazim, Khaled; Ekart, Robert; Valdivielso, Jose; Fouque, Denis; London, Gerard M.; Massy, Ziad; Ruggenenti, Petro; Porrini, Esteban; Wiecek, Andrej; Zoccali, Carmine; Mallamaci, Francesca; Hornum, Mads

    SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA

    NEPHROLOGY DIALYSIS TRANSPLANTATION 34 208-230. .

    [doi:10.1093/ndt/gfy407]

  • Chang AR; Grams ME; Ballew SH; Bilo H; Correa A; Evans M; Gutierrez OM; Hosseinpanah F; Iseki K; Kenealy T; Klein B; Kronenberg F; Lee BJ; Li Y; Miura K; Navaneethan SD; Roderick PJ; Valdivielso JM; Visseren FLJ; Zhang L; Gansevoort RT; Hallan SI; Levey AS; Matsushita K; Shalev V; Woodward M; CKD Prognosis Consortium (CKD-PC)

    Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium

    BMJ-BRITISH MEDICAL JOURNAL 364 k5301-. .

    [doi:10.1136/bmj.k5301]

  • Valdivielso JM; Jacobs-Cachá C; Soler MJ

    Sex hormones and their influence on chronic kidney disease.

    CURR OPIN NEPHROL HY 28 1-9. .

    [doi:10.1097/MNH.0000000000000463]

  • Forné, Carles; Cambray, Serafi; Bermudez-Lopez, Marcelino; Fernandez, Elvira; Bozic, Milica; Valdivielso, Jose M

    Machine learning analysis of serum biomarkers for cardiovascular risk assessment in chronic kidney disease

    CKJ: Clinical Kidney Journal -. .

    [doi:10.1093/ckj/sfz094]

  • Borràs, Mercè; Cambray, Serafí; Crespo-Masip, Maria; Pérez-Fontán, Miguel; Bozic, Milica; Bermudez-López, Marcelino; Fernández, Elvira; Betriu, Àngels; Valdivielso, José M.

    Peritoneal Dialysis Is an Independent Factor Associated to Lower lntima Media Thickness in Dialysis Patients Free From Previous Cardiovascular Disease

    Frontiers in physiology 9 1743-1743. .

    [doi:10.3389/fphys.2018.01743]

  • Ferro, Charles J.; Mark, Patrick B.; Kanbay, Mehmet; Sarafidis, Pantelis; Heine, Gunnar H.; Rossignol, Patrick; Massy, Ziad A.; Mallamaci, Francesca; Valdivielso, Jose M.; Malyszko, Jolanta; Verhaar, Marianne C.; Ekart, Robert; Vanholder, Raymond; London, Gerard; Ortiz, Alberto; Zoccali, Carmine

    Lipid management in patients with chronic kidney disease

    NATURE REVIEWS NEPHROLOGY 14 727-749. .

    [doi:10.1038/s41581-018-0072-9]

  • Montserrat-Capdevila, Josep; Seminario MA; Godoy, Pere; Marsal JR; Ortega, Marta; Pujol, Jesus; Castañ MT; Alseda, Miguel; Betriu À; Lecube, Albert; Portero, Manel; Purroy, Francisco; Valdivielso JM; Barbe, Ferran

    Prevalence of chronic obstructive pulmonary disease (COPD) not diagnosed in a population with cardiovascular risk factors

    MEDICINA CLINICA 151 383-389. .

    [doi:10.1016/j.medcli.2017.12.018]

  • Arcidiacono, Maria Vittoria; Rimondi, Erika; Maietti, Elisa; Melloni, Elisabetta; Tisato, Veronica; Gallo, Stefania; Valdivielso JM; Fernandez, Elvira; Betriu À; Voltan, Rebecca; Zauli, Giorgio; Volpato, Stefano; Secchiero, Paola

    Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease

    PLOS ONE 13 e0203716-. .

    [doi:10.1371/journal.pone.0203716]

Projectes

  • PAPEL DE LA 1-25 DIHIDROXIVITAMINA D3 EXTRARRENAL EN LA PROGRESION DE LA ARTERIOPATIA UREMICA
  • ADVENTITIAL VASA VASORUM AND SUBCLINICAL ATHEROMATOSIS